11. Neutrophil function in patients with chronic hepatitis C (CHC) undergoing triple antiviral therapy (TT) with first and second generation protease inhibitors (PI). (15th February 2015) Authors: Gambato, M.; Caro-Pérez, N.; Cañete, N.; Mariño, Z.; Lens, S.; Sánchez-Tapias, JM.; Carrion, J.; Pérez-del-Pulgar, S.; Juan, M.; Londoño, M.; Forns, X. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C. Issue 3 (18th November 2015) Authors: Lens, S.; Torres, F.; Puigvehi, M.; Mariño, Z.; Londoño, M.‐C.; Martinez, S. M.; García‐Juárez, I.; García‐Criado, Á.; Gilabert, R.; Bru, C.; Solà, R.; Sanchez‐Tapias, J. M.; Carrión, J. A.; Forns, X. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 3(2016) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Reply:1. Issue 2 (5th February 2013) Authors: Mensa, L.; Perez‐del‐Pulgar, S.; Forns, X. Journal: Hepatology Issue: Volume 57:Issue 2(2013:Feb.) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Residual HCV-RNA in liver explants from patients undergoing sofosbuvir and ribavirin treatment while awaiting liver transplantation is not associated with HCV relapse. (15th February 2015) Authors: Gambato, M.; Pérez-del-Pulgar, S.; Hedskog, C.; Svarovskia, J.; Paulson, M.S.; Denning, J.; Curry, M.P.; Caro-Pérez, N.; Londoño, M.C.; Forns, X. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Screnning of viral hepatitis in mental disorder patients: Psiqui-Clinic Programme. (1st June 2022) Authors: Cavero, M.; Planas, T.; Goikolea, J.; Lens, S.; Bartrés, C.; Colomer, L.; García, C.; Valentí, M.; Ruiz, V.; Rivas, Y.; Benabarre, A.; Catalan, R.; Masana, G.; Colom, J.; Forns, X.; Martin-Santos, R.; Mariño, Z. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Significant early and long-term improvement of neuropsychiatry symptomatology in HCV-infected patients after viral eradication with DAA. (1st June 2022) Authors: Martin-Santos, R.; Bartrés, C.; Nacar, L.; Navinés, R.; Cavero, M.; Lens, S.; Rodriguez-Tajes, S.; Pariante, J.C.; Horrillo, I.; Muñoz-Moreno, E.; Bargallo, N.; Capuron, L.; Meana, J.; Forns, X.; Mariño, Z. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies. Issue 4 (3rd November 2014) Authors: Manns, M. P.; Fried, M. W.; Zeuzem, S.; Jacobson, I. M.; Forns, X.; Poordad, F.; Peeters, M.; Fu, M.; Lenz, O.; Ouwerkerk‐Mahadevan, S.; Jessner, W.; Scott, J. A.; Kalmeijer, R.; De La Rosa, G.; Sinha, R.; Beumont‐Mauviel, M. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 4(2015) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infection. Issue 9 (14th March 2018) Authors: Oriolo, G.; Egmond, E.; Mariño, Z.; Cavero, M.; Navines, R.; Zamarrenho, L.; Solà, R.; Pujol, J.; Bargallo, N.; Forns, X.; Martin‐Santos, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 9(2018) Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. THU0298 Are Anti-La Antibodies A Potential Protection for Hepatitis C Virus Infection in SjÖGren Syndrome? Analysis in 663 Patients. (10th June 2014) Authors: Brito Zeron, P.; Kaveri, S.V.; Bové, A.; Retamozo, S.; Gheitasi, H.; Akasbi, M.; Gandía, M.; Soto-Cárdenas, M.J.; Pérez-de-Lis, M.; Pérez-Alvarez, R.; Kostov, B.; Sisό-Almirall, A.; Londoño, M.; Forns, X.; Ramos-Casals, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Undetectable HCV‐RNA at treatment‐week 8 results in high‐sustained virological response in HCV G1 treatment‐experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program. Issue 5 (14th October 2014) Authors: Bruno, S.; Bollani, S.; Zignego, A. L.; Pascasio, J. M.; Magni, C.; Ciancio, A.; Caremani, M.; Mangia, A.; Marenco, S.; Piovesan, S.; Chemello, L.; Babudieri, S.; Moretti, A.; Gea, F.; Colletta, C.; Perez‐Alvarez, R.; Forns, X.; Larrubia, J. R.; Arenas, J.; Crespo, J. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 5(2015) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗